NMDA
NMDA receptors (NMDARs) are voltage-dependent and ligand-gated ionotropic glutamate receptors that also require co-activation with glycine or D-serine. NMDA receptors are heterotetrameric and are comprised of GluN1, GluN2 (GluN2A, GluN2B, GluN2C, GluN2D), and GluN3 (GluN3A, GluN3B) subunits. Researchers can save 50% on NMDA receptor (NMDAR) agonists, antagonists, positive allosteric modulators (PAMs) and negative allosteric modulators (NAMs) from Hello Bio- they are up to half the price of other suppliers.
Clozapine N-oxide (CNO) (freebase) (HB1807)
Description:Prototypical DREADD activator. Clozapine metabolite.
Purity:>98%
- Description:
Dihydrochloride salt of CNO - the prototypical DREADD activator
Purity:>98%
Homovanillic acid (HB1902)
Description:Fluorimetric reagent. Catecholamine metabolite.
Purity:>99%
MNI-caged-L-Glutamate (HB0423)
Description:Caged glutamate that rapidly and efficiently releases glutamate when photolysed
Purity:>98%
±-Octopamine hydrochloride (HB2791)
Description:Invertebrate neurotransmitter. Chemogenetic DmOctβ1 receptor activator.
Purity:>99%
Perlapine (HB4889)
Description:Effective agonist for muscarinic-based DREADDs in vitro and in vivo. Non-CNO chemogenetic actuator
Purity:>98%
- Description:
Effective agonist for muscarinic-based DREADDs in vitro and in vivo. Non-CNO chemogenetic actuator. Water soluble.
Purity:>98%